Understanding New Healthcare Buyers

Leah Hoffmann

A medical device manufacturer had just launched a product that dramatically cut patient recovery time—as well as recovery-related expenses. Could the company accelerate sales by working with healthcare payers and IDNs, rather than physicians?

Business Talent Group assembled a tight two-person team of healthcare experts. One was a senior consultant and previous lead of McKinsey’s life science practice. She was joined by an experienced health economist with a strong network in the payer space. Together, our team interviewed payer representatives, refined value propositions, and provided a topline estimate of the opportunity’s magnitude.

After analyzing market attractiveness and reimbursement options, the consultants concluded that profit margins were too slim for the new buyer group.

 

Previous Article
Accelerating an Oncology Drug Launch
Accelerating an Oncology Drug Launch

A F300 pharma company was preparing to launch a new oncology drug. But its understaffed pricing and market ...

Next Article
Assessing a Digital Wellness App
Assessing a Digital Wellness App

The VP of Business Development at an F200 health company was struggling with pricing pressures following th...